165 related articles for article (PubMed ID: 31888499)
1. Evaluation of alterations in serum immunoglobulin concentrations in components of metabolic syndrome, obesity, diabetes, and dyslipidemia.
Lin D; Bridgeman MB; Brunetti L
BMC Cardiovasc Disord; 2019 Dec; 19(1):319. PubMed ID: 31888499
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities.
Gonzalez-Quintela A; Alende R; Gude F; Campos J; Rey J; Meijide LM; Fernandez-Merino C; Vidal C
Clin Exp Immunol; 2008 Jan; 151(1):42-50. PubMed ID: 18005364
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum levels of immunoglobulins and metabolic syndrome in an adult population: A population study from the TCLSIH cohort study.
Wang X; Fu J; Gu Y; Chi VTQ; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Bao X; Zhang S; Liu M; Wang Y; Lu Z; Wang L; Zheng L; Wang X; Tian C; Sun S; Zhou M; Jia Q; Song K; Niu K
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):916-922. PubMed ID: 31377185
[TBL] [Abstract][Full Text] [Related]
4. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
[TBL] [Abstract][Full Text] [Related]
5. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytes and immunoglobulin patterns across the threshold of severe obesity.
Marzullo P; Minocci A; Giarda P; Marconi C; Tagliaferri A; Walker GE; Scacchi M; Aimaretti G; Liuzzi A
Endocrine; 2014 Apr; 45(3):392-400. PubMed ID: 23801194
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
Lyamuya EF; Matee MI; Kasubi M; Scheutz F
East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
[TBL] [Abstract][Full Text] [Related]
9. In Vivo and Ex Vivo Inflammatory Markers of Common Metabolic Phenotypes in Humans.
Mærkedahl RB; Frøkiær H; Stenbæk MG; Nielsen CB; Lind MV; Lundtoft C; Bohr MB; Ibrügger S; Metzdorff SB; Vestergaard H; Pedersen O; Lauritzen L
Metab Syndr Relat Disord; 2018 Feb; 16(1):29-39. PubMed ID: 29319419
[TBL] [Abstract][Full Text] [Related]
10. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
11. Determinants and Reference Ranges of Serum Immunoglobulins in Middle-Aged and Elderly Individuals: a Population-Based Study.
Khan SR; Chaker L; Ikram MA; Peeters RP; van Hagen PM; Dalm VASH
J Clin Immunol; 2021 Nov; 41(8):1902-1914. PubMed ID: 34505230
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
[TBL] [Abstract][Full Text] [Related]
13. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.
Kovanen PT; Mänttäri M; Palosuo T; Manninen V; Aho K
Arch Intern Med; 1998 Jul; 158(13):1434-9. PubMed ID: 9665352
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of IgG, IgA, and IgM in retired racing Greyhound dogs.
Clemente M; Marín L; Iazbik MC; Couto CG
Vet Clin Pathol; 2010 Dec; 39(4):436-9. PubMed ID: 21198733
[TBL] [Abstract][Full Text] [Related]
15. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
[TBL] [Abstract][Full Text] [Related]
16. Measurement of IgG, IgM and IgA concentrations in canine serum, saliva, tears and bile.
German AJ; Hall EJ; Day MJ
Vet Immunol Immunopathol; 1998 Jul; 64(2):107-21. PubMed ID: 9661261
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus: a registry-based study. The Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Winnock F; Lebleu F; Keymeulen B; Van der Auwera B; Falorni A; Dorchy H; Féry F; Pipeleers DG
Pancreas; 1998 Jan; 16(1):50-9. PubMed ID: 9436863
[TBL] [Abstract][Full Text] [Related]
18. Ferritin, metabolic syndrome and its components: A systematic review and meta-analysis.
Suárez-Ortegón MF; Ensaldo-Carrasco E; Shi T; McLachlan S; Fernández-Real JM; Wild SH
Atherosclerosis; 2018 Aug; 275():97-106. PubMed ID: 29886355
[TBL] [Abstract][Full Text] [Related]
19. Metabolic-related markers and inflammatory factors as predictors of dyslipidemia among urban Han Chinese adults.
Lian Y; Xie L; Liu Y; Tang F
Lipids Health Dis; 2019 Aug; 18(1):167. PubMed ID: 31472689
[TBL] [Abstract][Full Text] [Related]
20. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
